Sriram Balasubramanian

Summary

Affiliation: Pharmacyclics Inc
Country: USA

Publications

  1. ncbi A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
    S Balasubramanian
    Department of Cancer Biology, Pharmacyclics Inc, Sunnyvale, CA 94085, USA
    Leukemia 22:1026-34. 2008
  2. ncbi Isoform-specific histone deacetylase inhibitors: the next step?
    Sriram Balasubramanian
    Department of Cancer Biology, Pharmacyclics, Inc, Sunnyvale, CA 94085, United States
    Cancer Lett 280:211-21. 2009

Collaborators

Detail Information

Publications2

  1. ncbi A novel histone deacetylase 8 (HDAC8)-specific inhibitor PCI-34051 induces apoptosis in T-cell lymphomas
    S Balasubramanian
    Department of Cancer Biology, Pharmacyclics Inc, Sunnyvale, CA 94085, USA
    Leukemia 22:1026-34. 2008
    ....
  2. ncbi Isoform-specific histone deacetylase inhibitors: the next step?
    Sriram Balasubramanian
    Department of Cancer Biology, Pharmacyclics, Inc, Sunnyvale, CA 94085, United States
    Cancer Lett 280:211-21. 2009
    ..The current status of isoform-specific inhibitor development is analyzed, especially inhibitors of HDAC1, 2, 4 and 8 enzymes, and the potential clinical utility of these compounds is discussed...